Meridian Bioscience (VIVO) Tops Q2 EPS by 3c, Beat on Revenues; Reaffirms FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Meridian Bioscience (VIVO) Declares $0.125 Quarterly Dividend; 3.5% Yield
April 27, 2017 7:56 AM EDTMeridian Bioscience (NASDAQ: VIVO) declared a quarterly dividend of $0.125 per share, or $0.5 annualized.
The dividend will be payable on May 18, 2017, to stockholders of record on May 8, 2017, with an ex-dividend date of May 4, 2017.
The annual yield on the dividend is 3.5 percent.
For... More



